ImmunityBio, Inc. (FRA:26CA)
Germany · Delayed Price · Currency is EUR 1.739
+0.023 (1.34%)
Last updated: Jan 5, 2026, 3:33 PM CET
ImmunityBio Market Cap
ImmunityBio has a market cap or net worth of €1.97 billion as of January 9, 2026. Its market cap has increased by 5.22% in one year.
Market Cap
1.97B
Enterprise Value
2.49B
Revenue
70.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.74
Market Cap Chart
Since March 10, 2021, ImmunityBio's market cap has decreased from 12.47B to 1.97B, a decrease of -84.17%. That is a compound annual growth rate of -31.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 1.97B | 18.78% |
| Dec 31, 2025 | 1.66B | -8.00% |
| Dec 31, 2024 | 1.81B | -40.46% |
| Dec 29, 2023 | 3.03B | 56.14% |
| Dec 30, 2022 | 1.94B | -8.68% |
| Dec 31, 2021 | 2.13B | -82.94% |
| Mar 10, 2021 | 12.47B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.94B |
| Allianz SE | 148.37B |
| Deutsche Telekom AG | 134.57B |
| Siemens Energy AG | 105.59B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.49B |
| Deutsche Bank Aktiengesellschaft | 63.01B |